MicroRNA 5006 (MIR5006)

MicroRNA 5006 (MIR5006) is a short, non-coding RNA (20–24 nucleotides) processed through a canonical miRNA pathway: transcribed by RNA polymerase II, cleaved by Drosha (nucleus) to form a hairpin precursor, exported to the cytoplasm, and further processed by Dicer to yield a mature miRNA. Mature miRNAs are incorporated into the RNA-induced silencing complex (RISC), where they guide sequence-specific targeting of mRNAs, typically resulting in inhibition or destabilization of target mRNAs[1][2][5][9]. While microRNAs broadly fine-tune gene expression and can be involved in cell differentiation, proliferation, apoptosis, and more, there is currently **no experimental data, known biological role, nor any disease association specifically described for MIR5006**[1]. MIR5006 remains a predicted entity within reference databases, with no indication of established gene targets, clinical impact, or drug interactions. MIR5006 stands for **MicroRNA 5006**, a predicted human miRNA gene (hsa-mir-5006) with no validated molecular function, disease role, or therapeutic relevance[1]. It is classified as a non-coding regulatory RNA, but insufficient information is available for structured biomedical application.

Other names

MIR5006hsa-mir-5006